This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Axceso Biopharma Co., Ltd., Dongjin Semichem Co., Ltd.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Innovations of Sung Il Yoon
Introduction
Sung Il Yoon is a notable inventor based in Hwaseong, South Korea. He has made significant contributions to the field of pharmaceuticals and materials science. With a total of 2 patents, his work focuses on innovative compounds and compositions that have the potential to impact various industries.
Latest Patents
One of his latest patents is for a pyrimido pyrimidinone compound and a pharmaceutical composition comprising the same. This invention discloses a pyrimido pyrimidinone compound that effectively inhibits PD-L1 expression. The pharmaceutical composition containing this compound serves as an active ingredient and is intended for the treatment or prevention of cancer. Another significant patent involves a polymerizable compound, a polymerizable composition, and an optical film utilizing the same. This invention aims to exhibit superior optical properties across a wide wavelength range by reducing wavelength dependence or demonstrating reverse-wavelength dispersibility.
Career Highlights
Sung Il Yoon has worked with prominent companies such as Dongjin Semichem Co., Ltd. and Axceso Biopharma Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative solutions in his field.
Collaborations
He has collaborated with talented individuals, including Hyebin Yoo and Si-Eun Yun, which has further enriched his work and research.
Conclusion
Sung Il Yoon's contributions to innovation through his patents and collaborations highlight his role as a significant inventor in the pharmaceutical and materials science sectors. His work continues to pave the way for advancements in cancer treatment and optical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
